The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients

被引：34
|
作者：
Lau, Winnie W. Y. [1 ,2 ,3 ]
Hannah, Rebecca [1 ,2 ,3 ]
Green, Anthony R. [1 ,2 ,3 ,4 ]
Goettgens, Bertie [1 ,2 ,3 ]
机构：
[1] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
[2] Univ Cambridge, Wellcome Trust, Stem Cell Inst, Med Res Council, Cambridge, England
[3] Univ Cambridge, Dept Haematol, Cambridge, England
[4] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
来源：
BLOOD | 2015年 / 125卷 / 10期
基金：
英国生物技术与生命科学研究理事会; 英国惠康基金; 英国医学研究理事会;
关键词：
MYELOPROLIFERATIVE NEOPLASMS; ENRICHMENT ANALYSIS; MUTATIONS; CELLS;
D O I：
10.1182/blood-2014-12-618074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1679 / 1681
页数：3
相关论文
共 50 条
  • [1] JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles
    Hekimoglu, Hilal
    Toprak, Selin Fulya
    Sozer, Selcuk
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (01) : 13 - 21
  • [2] Morphologic Evaluation of CALR and JAK2V617F-Positive Primary Myelofibrosis (PMF)
    Wood, Adam
    Viswanatha, David
    Reichard, Kaaren
    Hanson, Curtis
    Chen, Dong
    Tefferi, Ayalew
    He, Rong
    LABORATORY INVESTIGATION, 2015, 95 : 387A - 387A
  • [3] Morphologic Evaluation of CALR and JAK2V617F-Positive Primary Myelofibrosis (PMF)
    Wood, Adam
    Viswanatha, David
    Reichard, Kaaren
    Hanson, Curtis
    Chen, Dong
    Tefferi, Ayalew
    He, Rong
    MODERN PATHOLOGY, 2015, 28 : 387A - 387A
  • [4] Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
    Mohamad Cherry
    Mohamad Khawandanah
    Zhizhuang Joe Zhao
    Samer Srour
    Howard Ozer
    George Selby
    Bassam Ghabache
    Aref Al-Kali
    Annals of Hematology, 2015, 94 : 717 - 719
  • [5] Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
    Cherry, Mohamad
    Khawandanah, Mohamad
    Zhao, Zhizhuang Joe
    Srour, Samer
    Ozer, Howard
    Selby, George
    Ghabache, Bassam
    Al-Kali, Aref
    ANNALS OF HEMATOLOGY, 2015, 94 (04) : 717 - 719
  • [6] Chorea Associated with JAK2V617F-Positive Essential Thrombocythemia
    Calculli, Alessandra
    Arceri, Sebastiano
    Pisani, Antonio
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (01): : 154 - 155
  • [7] The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
    Olschok, Kathrin
    Altenburg, Bianca
    de Toledo, Marcelo A. S.
    Maurer, Angela
    Abels, Anne
    Beier, Fabian
    Gezer, Deniz
    Isfort, Susanne
    Paeschke, Katrin
    Bruemmendorf, Tim H.
    Zenke, Martin
    Chatain, Nicolas
    Koschmieder, Steffen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Characterization of murine JAK2V617F-positive myeloproliferative disease
    Bumm, Thomas G. P.
    Elsea, Collin
    Corbin, Amie S.
    Loriaux, Marc
    Sherbenou, Daniel
    Wood, Lisa
    Deininger, Jutta
    Silver, Richard T.
    Druker, Brian J.
    Deininger, Michael W. N.
    CANCER RESEARCH, 2006, 66 (23) : 11156 - 11165
  • [9] Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia
    Puigdecanet, E.
    Espinet, B.
    Lozano, J. J.
    Sumoy, L.
    Bellosillo, B.
    Arenillas, L.
    Alvarez-Larran, A.
    Sole, F.
    Serrano, S.
    Besses, C.
    Florensa, L.
    LEUKEMIA, 2008, 22 (07) : 1368 - 1376
  • [10] The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
    M O Holmström
    M D Hjortsø
    S M Ahmad
    Ö Met
    E Martinenaite
    C Riley
    P Straten
    I M Svane
    H C Hasselbalch
    M H Andersen
    Leukemia, 2017, 31 : 495 - 498
12345